UBS Adjusts Price Target on Albemarle to $108 From $102, Maintains Neutral Rating
Mizuho Securities Maintains Albemarle(ALB.US) With Hold Rating, Raises Target Price to $110
Berenberg Bank Sticks to Its Hold Rating for Albemarle (ALB)
RBC Capital Maintains Albemarle(ALB.US) With Buy Rating, Raises Target Price to $133
KeyBanc Maintains Albemarle(ALB.US) With Buy Rating, Cuts Target Price to $127
Albemarle Is Maintained at Overweight by Keybanc
Albemarle Analyst Ratings
Albemarle (ALB) Gets a Hold From Scotiabank
RBC Capital Keeps Their Buy Rating on Albemarle (ALB)
KeyBanc Adjusts Price Target on Albemarle to $127 From $132, Keeps Overweight Rating
Albemarle Is Maintained at Outperform by Oppenheimer
Albemarle Analyst Ratings
BofA Securities Maintains Albemarle(ALB.US) With Buy Rating
Morgan Stanley Maintains Albemarle(ALB.US) With Sell Rating, Maintains Target Price $73
Oppenheimer Maintains Albemarle(ALB.US) With Buy Rating, Cuts Target Price to $170
Oppenheimer Sticks to Its Buy Rating for Albemarle (ALB)
Mizuho Adjusts Price Target on Albemarle to $105 From $103, Maintains Neutral Rating
Evercore Maintains Albemarle(ALB.US) With Buy Rating, Maintains Target Price $170
Analysts Conflicted on These Materials Names: Nutrien (NTR), Royal Gold (RGLD) and Albemarle (ALB)
TD Cowen Maintains Albemarle(ALB.US) With Hold Rating, Maintains Target Price $115